학술논문
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
Document Type
Article
Author
Xia, ShengLi; Zhang, YunTao; Wang, YanXia; Wang, Hui; Yang, YunKai; Gao, George Fu; Tan, WenJie; Wu, GuiZhen; Xu, Miao; Lou, ZhiYong; Huang, WeiJin; Xu, WenBo; Huang, BaoYing; Wang, Wei; Zhang, Wei; Li, Na; Xie, ZhiQiang; Zhu, Xiujuan; Ding, Ling; You, WangYang; Zhao, YuXiu; Zhao, Jun; Huang, LiLi; Shi, XueZhong; Yang, YongLi; Xu, GuangXue; Wang, WenLing; Liu, PeiPei; Ma, Meng; Qiao, YuLing; Zhao, SuHua; Chai, JingJing; Li, QinQin; Fu, Hui; Xu, Ying; Zheng, XiaoTong; Guo, WanShen ; Yang, XiaoMing
Source
In The Lancet Infectious Diseases February 2022 22(2):196-208
Subject
Language
ISSN
1473-3099